KR790001482B1 - Process for preparing phenothiazin derivatives - Google Patents

Process for preparing phenothiazin derivatives Download PDF

Info

Publication number
KR790001482B1
KR790001482B1 KR7803594A KR780003594A KR790001482B1 KR 790001482 B1 KR790001482 B1 KR 790001482B1 KR 7803594 A KR7803594 A KR 7803594A KR 780003594 A KR780003594 A KR 780003594A KR 790001482 B1 KR790001482 B1 KR 790001482B1
Authority
KR
South Korea
Prior art keywords
group
phenothiazine
formula
methyl
solution
Prior art date
Application number
KR7803594A
Other languages
Korean (ko)
Inventor
이화석
최충권
Original Assignee
천병두
재단법인 한국과학기술연구소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 천병두, 재단법인 한국과학기술연구소 filed Critical 천병두
Priority to KR7803594A priority Critical patent/KR790001482B1/en
Application granted granted Critical
Publication of KR790001482B1 publication Critical patent/KR790001482B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

내용 없음.No content.

Description

페노티아진 유도체의 제조방법Method for preparing phenothiazine derivatives

본 발명은 일반식(I)로 표시되는 페노티아진(phenothiazine) 유도체의 새롭고도 진보된 제조방법에 관한 것이다.The present invention relates to a new and advanced process for the preparation of phenothiazine derivatives represented by general formula (I).

Figure kpo00001
Figure kpo00001

여기서 A는 2-디메틸아미노프로필기, 3-디메틸아미노프로필기, 2-(N-메틸피페리디노) 메틸기, 2-(1-메틸-2-피페리딜) 에틸기, 3-(1-메틸-4-피페라지닐)-프로필기, N'-아세톡시에틸피페라지닐-N-프로필기, 3-디메틸아미노-2-메틸프로필기 및 N'-헵타노일옥시 에틸피페라지닐-N-프로필기이다. 한편 Y는 수소, 메틸기, 에틸기, 염소, 트리플루오르메틸기, 메톡시기, 에톡시기, 메틸티오기, 에틸티오기, 메틸술피닐기, 에틸술포닐기, 디메틸아미노술폰아미드기, 아세틸기, 프로피오닐기 및 부타노일기이다. 이 유도체들 중 일부는 알려져 있는 화합물이며 진통제, 진양제, 항히스타민제, 신경안정제 등의 약품으로 사용되고 있다.Where A is 2-dimethylaminopropyl group, 3-dimethylaminopropyl group, 2- (N-methylpiperidino) methyl group, 2- (1-methyl-2-piperidyl) ethyl group, 3- (1-methyl -4-piperazinyl) -propyl group, N'-acetoxyethylpiperazinyl-N-propyl group, 3-dimethylamino-2-methylpropyl group and N'-heptanoyloxy ethylpiperazinyl-N- It is a profile machine. Y represents hydrogen, methyl, ethyl, chlorine, trifluoromethyl, methoxy, ethoxy, methylthio, ethylthio, methylsulfinyl, ethylsulfonyl, dimethylaminosulfonamide, acetyl, propionyl and Butanoyl group. Some of these derivatives are known compounds and are used in medicines such as painkillers, antiangiogenic agents, antihistamines, and neurostabilizers.

본 발명을 더 자세히 말하자면 일반식(Ⅱ)로 표시되는 할로아민 측쇄를 구조식(Ⅲ)의 페노티아진 핵과 결합시키는 방법에 관한 것이다.More specifically, the present invention relates to a method of combining the haloamine side chain represented by the general formula (II) with the phenothiazine nucleus of the structural formula (III).

Figure kpo00002
Figure kpo00002

여기서 A와 Y는 전술한 바와 같으며, X는 할로겐이며, 이들의 제법은 다음과 같은 특허 및 문헌에 기재되어 있다.Wherein A and Y are as described above, X is halogen, and their preparation is described in the following patents and documents.

U.S. Pat. 2,645,640 (July 14, 1953)U.S. Pat. 2,645,640 (July 14, 1953)

U.S. Pat. 2,837,518 (June 3, 1958)U.S. Pat. 2,837,518 (June 3, 1958)

U.S. Pat. 2,902,484 (1959)U.S. Pat. 2,902,484 (1959)

Helv. Chim. Acta. 41, 1,072 (1958)Helv. Chim. Acta. 41, 1,072 (1958)

이들 공지의 방법에 의하면 페노티아진 유도체(I)의 제조방법은 (1) 디페닐아민 유도체(Ⅳ)와 황을 요오드 촉매하에서 가열에 의한 고리화 반응, (2) 디페닐 황유도체(V)의 축합에 의한 고리화 반응 (3) 측쇄인 할로아민(Ⅱ)와 페노티아진 핵(Ⅲ)의 결합에 의한 것이다.According to these known methods, the method for producing a phenothiazine derivative (I) includes (1) a cyclization reaction of diphenylamine derivative (IV) and sulfur by heating under an iodine catalyst, (2) diphenyl sulfur derivative (V) Cyclization reaction by condensation of (3) It is due to the coupling | bonding of the haloamine (II) which is a side chain, and the phenothiazine nucleus (III).

Figure kpo00003
Figure kpo00003

이중(3)의 반응에 있어서, 축합제로는 나트륨아미드, 리듐히드리드, 노르말-부틸리튬, 페닐리튬 등을 사용하였다. 그러나 이들 축합제는 가격면에서 고가일뿐만 아니라 취급하기도 어려우며 또한 페노티아진핵과 측쇄를 연결시킬때에 반응시간이 길어 비경제적인 결점을 가지고 있다.In the reaction (2), sodium amide, lithium hydride, normal-butyllithium, phenyl lithium, and the like were used as the condensing agent. However, these condensers are not only expensive in terms of price, they are difficult to handle, and also have an uneconomical disadvantage due to the long reaction time when linking phenothiazine nuclei and side chains.

본 발명에서는 위의 결점을 제거할 수 있는 새롭고도 진보된 구조식(I)의 페노티아진 유도체의 제조방법을 제공하고자 한다. 본 제조방법은 알카리금속수산화물(Ⅳ)과 페노티아진 핵(Ⅲ)을 비활성 용매에 넣고 함께 끊는 증류를 하여 생성되는 물을 제거하고 구조식(Ⅶ)의 페노티아진의 금속염을 얻은 후 구조식(Ⅱ)의 측쇄를 가하여 구조식(I)의 페노티아진 유도체를 짧은 반응시간 (2-6시간)에서 높은 수율로 얻는 방법이다. 여기서 구조식(Ⅵ)의 알카리금속 수산화물이란 수산화리튬, 수산화칼륨, 수산화나트륨 등을 말하며 바람직한 화합물은 수산화칼륨 또는 수산화나트륨이다.The present invention seeks to provide a new and advanced process for the preparation of phenothiazine derivatives of formula (I) which can eliminate the above drawbacks. In this method, the alkali metal hydroxide (IV) and the phenothiazine nucleus (III) are put in an inert solvent, and distillation is carried out to remove the water produced, obtaining a metal salt of phenothiazine of the structural formula (II). ) And the phenothiazine derivative of formula (I) is obtained in high yield in a short reaction time (2-6 hours). Here, the alkali metal hydroxide of the formula (VI) refers to lithium hydroxide, potassium hydroxide, sodium hydroxide and the like, and preferred compounds are potassium hydroxide or sodium hydroxide.

구조식(Ⅲ)의 페노티아진 핵중의 Y는 수소, 메틸기, 에틸기, 염소, 트리플루오르메틸기, 메톡시기, 에톡시기, 메틸티오기, 에틸티오기, 메틸술피닐기, 에틸술포닐기, 디메틸아미노술폰아미드기, 아세틸기, 프로피오닐기, 또는 부타노일기이 다.Y in the phenothiazine nucleus of formula (III) is hydrogen, methyl group, ethyl group, chlorine, trifluoromethyl group, methoxy group, ethoxy group, methylthio group, ethylthio group, methylsulfinyl group, ethylsulfonyl group, dimethylaminosulfonamide Group, acetyl group, propionyl group, or butanoyl group.

비활성 용매는 비활성 방향족 유기용매를 지칭하며 이에 속하는 것은 벤젠, 톨루엔, 에틸벤젠, 크실렌 등이다.Inert solvents refer to inert aromatic organic solvents and include benzene, toluene, ethylbenzene, xylene and the like.

구조식(Ⅶ)의 금속염 화합물중 Y는 상술한 구조식(Ⅲ)의 Y와 동일하며, M은 리튬, 칼륨, 또는 나트륨이나 바람직한 금속은 칼륨과 나트륨이다.Of the metal salt compounds of the formula (Y), Y is the same as Y of the above-described formula (III), M is lithium, potassium, or sodium, but preferred metals are potassium and sodium.

구조식(Ⅱ)의 A-x중, A는 2-디메틸아미노프로필기, 3-디메틸아미노프로필기, 2-(1-메틸-2-피페리딜) 에틸기, 3-(1-메틸-4-피페라지닐) 프로필기, 2-(N-메틸피페리디노) 메틸기, 3-디메틸아미노-2-메틸프로필기, N'-아세톡시에틸피페라지닐-N-프로필기, N'-헵타노일옥시에틸피페라지닐-N-프로필기가 이에 해당되며 x는 클로라이드 또는 브로마이드를 나타내는바, 예컨대 A-x를 조합하면 2-디메틸아미노프로필클로라이드 또는 2-디메틸아미노프로필브로마이드가 된다.In Ax of Structural Formula (II), A is 2-dimethylaminopropyl group, 3-dimethylaminopropyl group, 2- (1-methyl-2-piperidyl) ethyl group, 3- (1-methyl-4-pipera Genyl) propyl group, 2- (N-methylpiperidino) methyl group, 3-dimethylamino-2-methylpropyl group, N'-acetoxyethyl piperazinyl-N-propyl group, N'-heptanoyloxyethyl This corresponds to a piperazinyl-N-propyl group, where x represents chloride or bromide, such as when combined Ax results in 2-dimethylaminopropylchloride or 2-dimethylaminopropylbromide.

생성물인 구조식(I)중, A는 구조식(Ⅱ)의 A와, Y도 구조식(Ⅲ)의 Y와 각각 동일하다.In structural formula (I) which is a product, A is the same as A of structural formula (II), and Y is also the same as Y of structural formula (III).

반응온도는 사용용매의 끓는점, 다시 말하면 각 용매의 환류온도가 다르기 때문에 한정지을 수 없으나 바람직한 반응온도는 70-150℃이다.The reaction temperature is not limited because the boiling point of the solvent, that is, the reflux temperature of each solvent is different, but the preferred reaction temperature is 70-150 ℃.

상기 반응진행의 이해를 돕기 위하여 개략적인 반응 메카니즘을 나타내면 다음과 같다.In order to assist in understanding the reaction progress, a schematic reaction mechanism is as follows.

Figure kpo00004
Figure kpo00004

제조과정의 이해를 더욱 증진시키는 일환으로 대표적인 예, 즉 2-메톡시페노티아진과 메틸클로라이드를 수산화나트륨 용액 존재하에 반응시키면 상기 반응 메카니즘에 의거 다음과 같 10-메틸-2-메톡시페노티아진을 제조할 수 있다.As a further example for further understanding of the manufacturing process, the reaction of 2-methoxyphenothiazine and methyl chloride in the presence of sodium hydroxide solution in accordance with the reaction mechanism is as follows. A azine can be prepared.

Figure kpo00005
Figure kpo00005

다음의 실시예는 본 발명을 더욱 상세히 예증하여 줄것이나 본 발명의 범위가 이에 국한 된다는 것은 아니다.The following examples illustrate the invention in more detail but are not intended to limit the scope thereof.

[실시예 1]Example 1

10-(3-디메틸아미노-2-메틸프로필)페노티아진의 제조Preparation of 10- (3-dimethylamino-2-methylpropyl) phenothiazine

Figure kpo00006
Figure kpo00006

2.4g (0.012몰)의 페노티아진과 0.95g (0.017몰)의 수산화칼륨을 35ml의 크실렌에 넣고 Dean-Stark 물분리기를 이용하여 이론량인 0.22ml의 물이 분리될때까지 환류한 다음 여기에 1.86g(0.0137몰)의 1-디메틸아미노-2-메틸-3-클로로프로판과 22.5ml의 크실렌 혼합액을 환류중에 50분 동안 서서히 적가한 후 계속하여 4시간 더 환류한다. 반응액을 실온도로 냉각한 후 30ml의 0.7N 염산으로 주출하고 이 수용액을 에테르로 씻고 2ml의 40% 수산화나트륨 수용액을 가하여 염기성으로 한 후 에테르로 4회 추출한다. 이 에테르 용액을 무수 황산마그네슘으로 건조시킨 후 감압증류시키면 3.53g(98.2%)의 기름상인 10-(3디메틸아미노-2-메틸프로필) 페노티아진을 얻는다.2.4 g (0.012 mole) of phenothiazine and 0.95 g (0.017 mole) of potassium hydroxide were added to 35 ml of xylene and refluxed using a Dean-Stark water separator until the theoretical 0.22 ml of water was separated. 1.86 g (0.0137 mol) of 1-dimethylamino-2-methyl-3-chloropropane and 22.5 ml of xylene mixture are slowly added dropwise during reflux for 50 minutes, followed by further reflux for 4 hours. The reaction solution was cooled to room temperature and then extracted with 30 ml of 0.7N hydrochloric acid. The aqueous solution was washed with ether, added with 2 ml of 40% sodium hydroxide aqueous solution to make basic, and extracted four times with ether. The ether solution was dried over anhydrous magnesium sulfate and distilled under reduced pressure to obtain 3.53 g (98.2%) of oily 10- (3dimethylamino-2-methylpropyl) phenothiazine.

이것을 박층크로마토그라피로 확인 하였는바, Rf값이 0.45(벤젠 : 에틸아세테이트=7.3)이었고, NMR스펙트럼(CDCl3, 100MHz)의 δ값은 다음과 같다.This was confirmed by thin layer chromatography. The R f value was 0.45 (benzene: ethyl acetate = 7.3), and the δ value of the NMR spectrum (CDCl 3 , 100 MHz) was as follows.

0.96(d,2H), 1.98-2.36(m,3H), 2.18(s,6H) 3.40-4.15(m,2H) 및 6.62-7.22(m,8H)0.96 (d, 2H), 1.98-2.36 (m, 3H), 2.18 (s, 6H) 3.40-4.15 (m, 2H) and 6.62-7.22 (m, 8H)

이의 녹는점을 확인한 결과, 본 발명품이 공지의 녹는점 67℃와 일치하였으며, 이외에도 공지의 염산염의 녹는점(217℃)과 거의 일치한 214-216℃, 공지의 타타르산염의 녹는점(160℃)과 거의 일치한 157 159℃이었다.As a result of confirming the melting point, the present invention coincides with the known melting point of 67 ℃, in addition to the melting point of known hydrochloride (217 ℃) 214-216 ℃, the melting point of known tartarate (160 ℃) It was 157 159 ° C., almost identical to).

[실시예 2]Example 2

10-(3-디메틸아미노-2-메틸프로필) 페노티아진의 제조Preparation of 10- (3-dimethylamino-2-methylpropyl) phenothiazine

Figure kpo00007
Figure kpo00007

4.8g(0.024몰)의 페노티아진과 1.41g(0.035몰)의 수산화나트륨을 35ml의 벤젠에 넣고 Dean-Stark 물 분리기를 이용하여 이론량인 0.44ml의 물이 분리될때까지 환류한 다음 여기에 3.72g(0.0274몰)의 1-디메틸아미노-2-메틸-3-클로로프로판과 30ml의 벤젠 혼합액을 환류중에 50분동안 서서히 적가한 후 계속하여 6시간 더 환류한다. 반응액을 실온도로 냉각한 후 30ml의 0.7N 염산으로 추출하고 이 수용액을 에테르로 씻고 2ml의 40% 수산화나트륨 수용액을 가하여 염기성으로 한 후 에테르로 4회 추출한다. 이 에테르 용액을 무수황산마그네슘으로 건조시킨 후 감압증류 시키면 6.56g(91.3%)의 기름상인 10-(3-디메틸아미노-2-메틸프로필) 페노티아진을 얻는다.4.8 g (0.024 mole) of phenothiazine and 1.41 g (0.035 mole) of sodium hydroxide were added to 35 ml of benzene and refluxed using a Dean-Stark water separator until the theoretical 0.44 ml of water was separated. 3.72 g (0.0274 mol) of 1-dimethylamino-2-methyl-3-chloropropane and 30 ml of benzene mixture were slowly added dropwise during reflux for 50 minutes, followed by further reflux for 6 hours. The reaction solution was cooled to room temperature and extracted with 30 ml of 0.7N hydrochloric acid. The aqueous solution was washed with ether, basicized with 2 ml of 40% sodium hydroxide aqueous solution, and extracted four times with ether. The ether solution was dried over anhydrous magnesium sulfate and distilled under reduced pressure to yield 6.56 g (91.3%) of oily 10- (3-dimethylamino-2-methylpropyl) phenothiazine.

생성물질의 확인은 실시예 1과 동일한 방법으로 하였는바 NMR의 δ값과 녹는점등의 확인결과도 실시예 1과 일치하였다.Confirmation of the product was carried out in the same manner as in Example 1, the results of confirmation, such as δ value and melting point of the NMR was also the same as in Example 1.

[실시예 3]Example 3

10-(3-디메틸아미노프로필) 페노티아진의 제조Preparation of 10- (3-dimethylaminopropyl) phenothiazine

Figure kpo00008
Figure kpo00008

4.8g(0.024몰)의 페노티아진과 1.89g(0.034몰)의 수산화칼륨을 50ml의 크실렌에 넣고 Dean-Stark 물 분리기를 이용하여 이론양인 0.43ml의 물이 분리될때까지 환류한 다음 여기에 3.44g(0.0275몰)의 1-디메틸아미노-3-클로로프로판을 27.5ml의 크실렌에 녹인 용액을 환류중에 50분동안 서서히 적가한 후 계속하여 4시간 더 환류한다. 반응액을 실온으로 냉각한 후 55ml의 0.7N 염산으로 추출하고 이 수용액을 에테르로 씻고 4ml의 40%수산화나트륨 수용액을 가하여 염기성으로 한 후 에테르로 4회 추출한다. 이 에테르 용액을 무수황산마그네슘으로 건조시킨 후 감압증류 시키면 기름상인 6.52g(97.6%)의 10-(3-디메틸아미노프로필) 페노티아진을 얻는다. 이것을 염산염으로 하여 공지의 분해온도와 비교 확인한 결과 공지의 분해온도 181℃와 거의 일치한 179℃이었고, 이외에도 NMR스펙트럼, 박층크로마토그라피로 재확인하였는바, 공지의 물질과 동일함을 확인 하였다.4.8 g (0.024 mole) of phenothiazine and 1.89 g (0.034 mole) of potassium hydroxide are placed in 50 ml of xylene and refluxed using a Dean-Stark water separator until the theoretical 0.43 ml of water is separated. A solution of g (0.0275 moles) of 1-dimethylamino-3-chloropropane in 27.5 ml of xylene was slowly added dropwise at reflux for 50 minutes, followed by further reflux for 4 hours. The reaction solution was cooled to room temperature and extracted with 55 ml of 0.7N hydrochloric acid. The aqueous solution was washed with ether, added with 4 ml of 40% sodium hydroxide aqueous solution to make basic and then extracted four times with ether. The ether solution was dried over anhydrous magnesium sulfate and distilled under reduced pressure to obtain 6.52 g (97.6%) of 10- (3-dimethylaminopropyl) phenothiazine as an oily phase. As a hydrochloride, it was confirmed to be compared with a known decomposition temperature and found to be 179 ° C, which was almost identical to a known decomposition temperature of 181 ° C. In addition, it was confirmed by NMR spectrum and thin layer chromatography to confirm that it was the same as a known substance.

[실시예 4]Example 4

10-(3-디메틸아미노프로필) 페노티아진의 제조Preparation of 10- (3-dimethylaminopropyl) phenothiazine

Figure kpo00009
Figure kpo00009

4.8g(0.024몰)의 페노티아진과 1.41g(0.035몰)의 수산화나트륨을 35ml의 톨루엔에 넣고 Dean-Stark 물분리기를 이용하여 이론량인 0.43ml의 물이 분리될때까지 환류한 다음 여기에 3.44g(0.0275몰)의 1-디메틸아미노-3-클로로프로판과 22.5ml의 톨루엔 혼합액을 환류중에 50분동안 서서히 적가한후 계속하여 5시간 더 환류한다. 반응액을 실온도로 냉각한후 55ml의 0.7N 염산으로 추출하고 이 수용액을 에테르로 씻고 4ml의 40% 수산화나트륨 수용액을 가하여 염기성으로 한 후 에테르로 4회 추출한다. 이 에테르용액을 무수황산마그네슘으로 건조시킨 후 감압증류시키면 6.18g(92.5%)의 기름상인 10-(3-디메틸아미노프로필) 페노티아진을 얻는다. 생성물질의 확인은 실시예 3과 동일한 방법으로 하였는바, 그 결과 NMR의 δ값과 녹는점등이 실시예 3과 일치 하였다.4.8 g (0.024 mole) of phenothiazine and 1.41 g (0.035 mole) of sodium hydroxide were added to 35 ml of toluene and refluxed using a Dean-Stark water separator until the theoretical 0.43 ml of water was separated. 3.44 g (0.0275 mol) of 1-dimethylamino-3-chloropropane and 22.5 ml of toluene mixture were slowly added dropwise during reflux for 50 minutes, followed by further reflux for 5 hours. The reaction solution was cooled to room temperature and extracted with 55 ml of 0.7N hydrochloric acid. The aqueous solution was washed with ether, added with 4 ml of 40% sodium hydroxide aqueous solution to make basic and then extracted four times with ether. The ether solution was dried over anhydrous magnesium sulfate and distilled under reduced pressure to yield 6.18 g (92.5%) of oily 10- (3-dimethylaminopropyl) phenothiazine. Confirmation of the product was carried out in the same manner as in Example 3, and as a result, δ value and melting point of NMR were consistent with Example 3.

[실시예 5]Example 5

10-[2-(1-메틸-2-피페리딜)에틸]-2-메틸티오페노티아진의 제조Preparation of 10- [2- (1-methyl-2-piperidyl) ethyl] -2-methylthiophenothiazine

Figure kpo00010
Figure kpo00010

2.95g(0.012몰)의 2-메틸티오페노티아진과 0.90g(0.016몰)의 수산화칼륨을 50ml의 크실렌에 혼합하여 Dean-Stark 물 분리기를 이용하여 이론량인 0.22ml의 물이 완전히 분리될때까지 환류한 다음, 이 용액에 2.04g(0.0132몰)의 2-(1-메틸-2-피페리딜) 에틸클로라이드와 22.5ml의 크실렌 혼합액을 환류중에 50분 동안 서서히 적가한 후 계속하여 4시간 더 환류한다. 반응액을 실온이 될때까지 냉각하여 30ml의 0.7N 염산으로 추출하고 이 수용액을 에테르로 세척한다. 산성인 세척액에 2ml의 40% 수산화나트륨 수용액을 가하여 염기성으로 한 후 에테르로 4회 추출한다.2.95 g (0.012 mole) of 2-methylthiophenothiazine and 0.90 g (0.016 mole) of potassium hydroxide are mixed with 50 ml of xylene, and the theoretical 0.22 ml of water is completely separated using Dean-Stark water separator. After refluxing, 2.04 g (0.0132 mol) of 2- (1-methyl-2-piperidyl) ethyl chloride and 22.5 ml of xylene mixed solution were slowly added dropwise to reflux for 50 minutes, followed by 4 hours. More reflux. The reaction solution is cooled to room temperature, extracted with 30 ml of 0.7N hydrochloric acid, and the aqueous solution is washed with ether. 2 ml of 40% aqueous sodium hydroxide solution was added to the acidic washing solution to make it basic and then extracted four times with ether.

이 에테르 용액을 무수황산마그네슘으로 24시간 건조시킨 후 감압 증류시키면 4.12g(92.5%)의 기름상의 10-[2-(1-메틸-2-피페리딜)에틸]-2-메틸티오페노티아진을 얻는다.The ether solution was dried over anhydrous magnesium sulfate for 24 hours, and then distilled under reduced pressure to obtain 4.12 g (92.5%) of oily 10- [2- (1-methyl-2-piperidyl) ethyl] -2-methylthiophenothi. Get azine.

이의 녹는점을 확인한 결과 공지의 녹는점 72-74℃와 일치한 72℃이었고 이외에도 NMR 스펙트럼, 박층크로마토그라피로 재확인하였더니 공지의 물질과 동일함을 확인하였다.As a result of checking the melting point thereof, the melting point was 72 ° C in accord with the known melting point 72-74 ° C, and in addition, the NMR spectrum and thin layer chromatography confirmed the same as the known material.

[실시예 6]Example 6

10-[2-(1-메틸-2-피페리딜)에틸]-2-메틸티오페노티아진의 제조Preparation of 10- [2- (1-methyl-2-piperidyl) ethyl] -2-methylthiophenothiazine

Figure kpo00011
Figure kpo00011

2.95g(0.012몰)의 2-메틸티오페노티아진과0.57g(0.017몰)의 수산화나트륨을 40ml의 에틸벤젠에 넣고 Dean-Stark 물 분리기를 이용하여 이론량인 0.22ml의 물이 분리될때까지 환류한 다음 여기에 2.04g(0.0132몰)의 2-(1-메틸-2-피페리딜) 에틸클로라이드와 25.0ml의 에틸벤젠 혼합액을 환류중에 50분동안 서서히 적가한 후 계속하여 4시간 더 환류한다. 반응액을 실온도로 냉각한 후 30ml의 0.7N 염산으로 추출하고 이 수용액을 에테르로 씻고 2ml의 40% 수산화나트륨 수용액을 가하여 염기성으로 한 후 에테르로 4회 추출한다. 이 에테르 용액을 무수황산마그네슘으로 건조시킨 후 감압증류 시키면 3.78g(84.8%)의 기름상인 10-[2-(1-메틸-2-피페리딜)에틸]-2-메틸티오페노티아진을 얻는다.2.95 g (0.012 mole) of 2-methylthiophenothiazine and 0.57 g (0.017 mole) of sodium hydroxide are added to 40 ml of ethylbenzene until the theoretical 0.22 ml of water is separated using a Dean-Stark water separator. After refluxing, a mixture of 2.04 g (0.0132 mol) of 2- (1-methyl-2-piperidyl) ethyl chloride and 25.0 ml of ethylbenzene was slowly added dropwise at reflux for 50 minutes, followed by further reflux for 4 hours. do. The reaction solution was cooled to room temperature and extracted with 30 ml of 0.7N hydrochloric acid. The aqueous solution was washed with ether, basicized with 2 ml of 40% sodium hydroxide aqueous solution, and extracted four times with ether. The ether solution was dried over anhydrous magnesium sulfate and distilled under reduced pressure to obtain 3.78 g (84.8%) of oily 10- [2- (1-methyl-2-piperidyl) ethyl] -2-methylthiophenothiazine. Get

생성물질의 환인은 실시예 5와 동일한 방법으로 하였는바, 그 결과 NMR의 δ값과 녹는점등이 실시예 5와 일치하였다.Acknowledgment of the product was carried out in the same manner as in Example 5, and as a result, the δ value and melting point of NMR were consistent with those in Example 5.

[실시예 7]Example 7

10-(2-디메틸아미노프로필) 페노티아진의 제조Preparation of 10- (2-dimethylaminopropyl) phenothiazine

Figure kpo00012
Figure kpo00012

4.8g(0.024몰)의 페노티아진과 1.41g(0.035몰)의 수산화나트륨을 50ml의 크실렌에 혼합하여 Dean-Stark 물 분리기를 이용하여 이론량인 0.43ml의 물이 완전히 분리될때까지 환류한다. 환류가 완료된 유기용액에 3.34g(0.027몰)의 1-N, N-디메틸-1-메틸-2-클로로에탄

Figure kpo00013
과 27.5ml의 크실렌 혼합액을 환류중에 1시간동안 서서히 적가하고 계속하여 4시간 더 환류한다. 반응액을 실온으로 냉각하여 55ml의 0.7N 염산으로 추출하고 이 수용액을 에테르로 세척한다.4.8 g (0.024 mole) of phenothiazine and 1.41 g (0.035 mole) of sodium hydroxide are mixed in 50 ml of xylene and refluxed using a Dean-Stark water separator until the theoretical 0.43 ml of water is completely separated. 3.34 g (0.027 mole) of 1-N, N-dimethyl-1-methyl-2-chloroethane in a refluxed organic solution
Figure kpo00013
And 27.5 ml of xylene mixture are slowly added dropwise for 1 hour while refluxing, followed by further reflux for 4 hours. The reaction solution is cooled to room temperature, extracted with 55 ml of 0.7N hydrochloric acid, and the aqueous solution is washed with ether.

산성인 세척액에 4ml의 40% 수산화나트륨 수용액을 가하여 염기성으로한 후, 에테르로 4회 추출한다.4 ml of 40% aqueous sodium hydroxide solution was added to the acidic washing solution to make it basic, and then extracted four times with ether.

이 에테르 용액을 무수 황산마그네슘으로 24시간 건조시킨 후 감압 증류시키면 5.38g(78.5%)의 기름상인 10-(2-디메틸아미노프로필) 페노티아진을 얻는다.The ether solution was dried over anhydrous magnesium sulfate for 24 hours and then distilled under reduced pressure to obtain 5.38 g (78.5%) of oily 10- (2-dimethylaminopropyl) phenothiazine.

이의 녹는점을 확인한 결과 공지의 녹는점 60℃와 거의 일치한 58℃이었고 이외에도 NMR스펙트럼, 박층크로마토그라피로 재확인 하였더니 공지의 물질과 동일함이 확인 되었다.As a result of confirming the melting point, the melting point was 58 ° C, which was almost identical to the known melting point of 60 ° C. In addition, reconfirmation by NMR spectrum and thin layer chromatography confirmed the same as the known material.

[실시예 8]Example 8

10-[3-(1-메틸-4-피페라지닐)프로필]-2-트리플루오르메틸페노티아진의 제조Preparation of 10- [3- (1-methyl-4-piperazinyl) propyl] -2-trifluoromethylphenothiazine

Figure kpo00014
Figure kpo00014

3.2g(0.012몰)의 2-트리플루오르메틸페노티아진과 0.71g(0.018몰)의 수산화나트륨을 50ml의 크실렌에 혼합하고 Dean-Stark 물 분리기를 이용하여 이론량인 0.22ml의 물이 완전히 분리될때까지 환류한다.3.2 g (0.012 mole) of 2-trifluoromethylphenothiazine and 0.71 g (0.018 mole) of sodium hydroxide were mixed in 50 ml of xylene and the theoretical 0.22 ml of water was completely separated using a Dean-Stark water separator. Reflux until

환류가 완료된 유기용액에 2.38g(0.013몰)의 3-(1-메틸-4-피페라지닐) 프로필클로라이드2.38 g (0.013 mol) of 3- (1-methyl-4-piperazinyl) propylchloride in refluxed organic solution

Figure kpo00015
Figure kpo00015

와 22.5ml의 크실렌 혼합액을 환류중에 1시간동안 서서히 적가한 후 계속하여 4시간 더 환류한다. 반응액을 실온으로 냉각하여 30ml의 0.7N 염산으로 추출하고 이 수용액을 에테르로 세척한다.And 22.5 ml of xylene mixture were slowly added dropwise for 1 hour during reflux, followed by further reflux for 4 hours. The reaction solution is cooled to room temperature, extracted with 30 ml of 0.7N hydrochloric acid, and the aqueous solution is washed with ether.

산성인 세척액에 2ml의 40% 수산화나트륨 수용액을 가하여 염기성으로 한후, 에테르로 4회 추출한다.2 ml of 40% aqueous sodium hydroxide solution was added to the acidic washing solution to make it basic, and then extracted four times with ether.

이 에테르용액을 무수 황산마그네슘으로 24시간 건조시킨 후 감압 증류시키면 3.90g(80.0%)의 기름상인 10-[3-(1-메틸-4-피페라지닐)프로필]-2-트리플루오르메틸페노티아진을 얻는다.The ether solution was dried over anhydrous magnesium sulfate for 24 hours, and then distilled under reduced pressure to give 3.90 g (80.0%) of oily 10- [3- (1-methyl-4-piperazinyl) propyl] -2-trifluoromethylfe. Get nottiazine.

이것을 공지의 녹는점(이의 염산염)과 비교 확인한 결과 공지의 녹는점 242-243℃와 일치한 242℃이었다.As a result of comparing this with the well-known melting point (its hydrochloride), it was 242 degreeC matching the well-known melting point 242-243 degreeC.

이외에도 NMR스펙트럼, 박층크로마토크라피로 재확인 하였더니 공지의 물질과 동일함을 확인하였다.In addition, reconfirmed by NMR spectrum, thin layer chromatography, it was confirmed that the same as the known material.

[실시예 9]Example 9

10-(3-디메틸아미노-2-메틸프로필)-2-메톡시페노티아진의 제조Preparation of 10- (3-dimethylamino-2-methylpropyl) -2-methoxyphenothiazine

Figure kpo00016
Figure kpo00016

5.5g(0.024몰)의 2-메톡시페노티아진과 1.42g(0.036몰)의 수산화나트륨을 50ml의 크실렌에 혼합하고 Dean-Stark 물 분리기를 이용하여 이론량인 0.43ml의 물이 완전히 분리될때까지 환류한다.When 5.5 g (0.024 mole) of 2-methoxyphenothiazine and 1.42 g (0.036 mole) of sodium hydroxide are mixed with 50 ml of xylene and the theoretical 0.43 ml of water is completely separated using the Dean-Stark water separator. Reflux until

환류가 완료된 유기용액에 3.66g(0.027몰)의 N,N-디메틸-2-메틸-3-클로로프로판3.66 g (0.027 mole) of N, N-dimethyl-2-methyl-3-chloropropane in refluxed organic solution

Figure kpo00017
과 22.5ml의 크실렌 혼합액을 환류중에 1시간동안 서서히 적가한 후 계속하여 4시간 더 환류한다.
Figure kpo00017
And 22.5 ml of xylene mixture are slowly added dropwise for 1 hour during reflux, followed by further reflux for 4 hours.

반응액을 실온으로 냉각하여 55ml의 0.7N 염산으로 추출하고 이 수용액을 에테르로 세척한다.The reaction solution is cooled to room temperature, extracted with 55 ml of 0.7N hydrochloric acid, and the aqueous solution is washed with ether.

산성인 세척액에 4ml의 40% 수산화나트륨 수용액을 가하여 염기성으로 한 후 에테르로 4회 추출한다.4 ml of 40% aqueous sodium hydroxide solution is added to the acidic washing solution to make it basic and then extracted four times with ether.

이 에테르 용액을 무수황산마그네슘으로 24시간 건조한 다음 감압 증류시키면 6.38g(81.0%)의 기름상인 10-(3-디메틸아미노-2-메틸프로필)-2-메톡시페노티아진을 얻는다.The ether solution was dried over anhydrous magnesium sulfate for 24 hours and then distilled under reduced pressure to yield 6.38 g (81.0%) of oily 10- (3-dimethylamino-2-methylpropyl) -2-methoxyphenothiazine.

이것을 공지의 녹는점과 비교 확인한 결과, 공지의 녹는점 44-48℃와 일치한 45℃이었다. 이외에도 NMR 스펙트럼, 박층크로마토그라피로 재확인 하였는바, 공지의 물질과 동일함을 확인 하였다.As a result of comparing this with the well-known melting point, it was 45 degreeC matching the well-known melting point 44-48 degreeC. In addition, it was confirmed by NMR spectrum and thin layer chromatography to confirm that it is the same as a known material.

Claims (1)

구조식(Ⅲ)의 페노티아진 핵과 구조식(Ⅵ)의 알칼리금속 수산화물을 물과 섞이지 않는 벤젠, 톨루엔, 크실렌, 에틸벤젠등의 비활성 유기용매중에서 함께 끓는 증류를 하여 생성된 물을 제거한 후 구조식(Ⅱ)의 할로아민 측쇄를 작용시키는 것을 특징으로 하는 구조식(I )의 페노티아진 유도체를 제조하는 방법.Phenothiazine nucleus of formula (III) and alkali metal hydroxides of formula (VI) are removed by boiling distillation together in an inert organic solvent such as benzene, toluene, xylene, ethylbenzene, etc. A method for preparing a phenothiazine derivative of formula (I), characterized in that the haloamine side chain of
Figure kpo00018
Figure kpo00018
여기서 구조식(Ⅲ) 중의 Y는 수소, 메틸티오기, 트리플루오르메틸기, 메톡시기를 나타내며 구조식(II)중의 x는 클로라이드 A는 2-디메틸아미노프로필기, 3-디메틸아미노-2-메틸프로필기, 3-디메틸아미노프로필기, 2-(1-메틸-2-피페리딜) 에틸기, 3-(1-메틸-4-피페라지닐) 프로필기를 나타내며, 구조식(Ⅵ)의 금속수산화물은 산화칼륨, 수산화나트륨를 나타내며, 구조식(Ⅰ)중의 A는 구조식(Ⅱ)의 A와 동일하며 Y는 구조식(Ⅲ)의 Y와 동일하다.Wherein Y in structural formula (III) represents hydrogen, methylthio group, trifluoromethyl group, and methoxy group, x in structural formula (II) represents chloride A is 2-dimethylaminopropyl group, 3-dimethylamino-2-methylpropyl group, 3-dimethylaminopropyl group, 2- (1-methyl-2-piperidyl) ethyl group, 3- (1-methyl-4-piperazinyl) propyl group, and the metal hydroxide of formula (VI) is potassium oxide, Represents sodium hydroxide, where A in structural formula (I) is the same as A in structural formula (II), and Y is the same as Y in structural formula (III).
KR7803594A 1978-11-27 1978-11-27 Process for preparing phenothiazin derivatives KR790001482B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR7803594A KR790001482B1 (en) 1978-11-27 1978-11-27 Process for preparing phenothiazin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR7803594A KR790001482B1 (en) 1978-11-27 1978-11-27 Process for preparing phenothiazin derivatives

Publications (1)

Publication Number Publication Date
KR790001482B1 true KR790001482B1 (en) 1979-10-23

Family

ID=19209318

Family Applications (1)

Application Number Title Priority Date Filing Date
KR7803594A KR790001482B1 (en) 1978-11-27 1978-11-27 Process for preparing phenothiazin derivatives

Country Status (1)

Country Link
KR (1) KR790001482B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10035795B1 (en) 2017-04-06 2018-07-31 Korea Institute Of Science And Technology Phenothiazine derivatives having CaM inhibitory activity

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10035795B1 (en) 2017-04-06 2018-07-31 Korea Institute Of Science And Technology Phenothiazine derivatives having CaM inhibitory activity

Similar Documents

Publication Publication Date Title
US2889322A (en) 3-methanesulphonyl phenthiazine derivatives
JP2004500324A (en) Novel synthesis and crystallization of piperazine ring-containing compounds
KR790001482B1 (en) Process for preparing phenothiazin derivatives
US3960856A (en) Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide
JP2782698B2 (en) Novel method for producing 9-amino-1,2,3,4-tetrahydroacridine
EP0148145B1 (en) Process for making nitrodiarylamines
SU880251A3 (en) Method of preparing thiochromane derivatives or their salts
EP0001991B1 (en) Phosphonium compounds, process for their preparation and process for the preparation of optical brighteners based on asymmetrically substituted stilbenes
JPH0361672B2 (en)
CN115850140B (en) P- (dimethyl sulfonium) benzenesulfonic acid inner salt and preparation method and application thereof
SU999967A3 (en) Process for producing 6-n-substituted 6-amino-3-pyridazinyl hydrizines or their salts
CH651031A5 (en) PROCESS FOR THE PREPARATION OF (TRIALCOXY BENZYL) -1 PIPERAZINES.
JPH0140833B2 (en)
JPS6136270A (en) Manufacture of 2_alkyl_4,5_dihydroxymethylimidazole
US3833648A (en) Process for preparing acylphenoxyaliphatic acid derivatives
US3312738A (en) Dibenzocycloheptenes and processes for the preparation thereof
JPS61189231A (en) Production of 4,4'-diaminodiphenylethane derivative
JPH02295946A (en) Substituterd biphenylcarboxylic acid and preparation thereof
JP3876933B2 (en) Method for producing hydrogen sulfate ester
US3549703A (en) Process for making n-(3-halopropyl)-n-methylhydrocarbon sulfonamides
KR810001319B1 (en) Process for the preparation of new isobutyramide derivatives
KR810000116B1 (en) Process for the production of urea derivatives
KR820002346B1 (en) Process for preparing 2-hydrazino-4-methylbenzothiazols
JPS6343382B2 (en)
KR920001768B1 (en) Process for preparing cromone carboxylate